Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical Species.

Foti RS, Biswas K, Aral J, Be X, Berry L, Cheng Y, Conner K, Falsey JR, Glaus C, Herberich B, Hickman D, Ikotun T, Li H, Long J, Huang L, Miranda LP, Murray J, Moyer B, Netirojjanakul C, Nixey TE, Sham K, Soto M, Tegley CM, Tran L, Wu B, Yin L, Rock DA.

Drug Metab Dispos. 2019 Aug 6. pii: dmd.119.087742. doi: 10.1124/dmd.119.087742. [Epub ahead of print]

2.

Changes in under-shoe traction and fluid drainage for progressively worn shoe tread.

Hemler SL, Charbonneau DN, Iraqi A, Redfern MS, Haight JM, Moyer BE, Beschorner KE.

Appl Ergon. 2019 Oct;80:35-42. doi: 10.1016/j.apergo.2019.04.014. Epub 2019 May 15.

PMID:
31280808
3.

Engineering NaV1.7 Inhibitory JzTx-V Peptides with a Potency and Basicity Profile Suitable for Antibody Conjugation To Enhance Pharmacokinetics.

Murray JK, Wu B, Tegley CM, Nixey TE, Falsey JR, Herberich B, Yin L, Sham K, Long J, Aral J, Cheng Y, Netirojjanakul C, Doherty L, Glaus C, Ikotun T, Li H, Tran L, Soto M, Salimi-Moosavi H, Ligutti J, Amagasu S, Andrews KL, Be X, Lin MJ, Foti RS, Ilch CP, Youngblood B, Kornecook TJ, Karow M, Walker KW, Moyer BD, Biswas K, Miranda LP.

ACS Chem Biol. 2019 Apr 19;14(4):806-818. doi: 10.1021/acschembio.9b00183. Epub 2019 Mar 27.

PMID:
30875193
4.

Efficient Separation of Light Lanthanides(III) by Using Bis-Lactam Phenanthroline Ligands.

Healy MR, Ivanov AS, Karslyan Y, Bryantsev VS, Moyer BA, Jansone-Popova S.

Chemistry. 2019 May 2;25(25):6326-6331. doi: 10.1002/chem.201806443. Epub 2019 Mar 27.

PMID:
30803070
5.

Enhancing selectivity of cation exchange with anion receptors.

Williams NJ, Roy S, Reynolds CO, Custelcean R, Bryantsev VS, Moyer BA.

Chem Commun (Camb). 2019 Mar 21;55(25):3590-3593. doi: 10.1039/c9cc00287a.

PMID:
30758374
6.

Recombinant Manganese Peroxidase Reduces A2E Burden in Age-Related and Stargardt's Macular Degeneration Models.

Moody KJ, Tinklepaugh J, Obert E, Grohn K, DeRosa JR, Lumen E, Moyer BS, Campbell S, Wolfe AJ, Sleeper MB, Bianchi AH, Fisher C, Applegate J, Leary E, LeClair N, Wortel D, Doyle RP, Rohrer B, Blanden AR.

Rejuvenation Res. 2018 Dec;21(6):560-571. doi: 10.1089/rej.2018.2146.

PMID:
30516450
7.

Guanidinium-Based Ionic Covalent Organic Framework for Rapid and Selective Removal of Toxic Cr(VI) Oxoanions from Water.

Jansone-Popova S, Moinel A, Schott JA, Mahurin SM, Popovs I, Veith GM, Moyer BA.

Environ Sci Technol. 2019 Jan 15;53(2):878-883. doi: 10.1021/acs.est.8b04215. Epub 2018 Oct 26.

PMID:
30351038
8.

Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis.

Wu B, Murray JK, Andrews KL, Sham K, Long J, Aral J, Ligutti J, Amagasu S, Liu D, Zou A, Min X, Wang Z, Ilch CP, Kornecook TJ, Lin MJ, Be X, Miranda LP, Moyer BD, Biswas K.

J Med Chem. 2018 Nov 8;61(21):9500-9512. doi: 10.1021/acs.jmedchem.8b00736. Epub 2018 Oct 22.

PMID:
30346167
9.

Surprisingly selective sulfate extraction by a simple monofunctional di(imino)guanidinium micelle-forming anion receptor.

Williams NJ, Seipp CA, Garrabrant KA, Custelcean R, Holguin E, Keum JK, Ellis RJ, Moyer BA.

Chem Commun (Camb). 2018 Sep 6;54(72):10048-10051. doi: 10.1039/c8cc05115a.

PMID:
30124224
10.

Outer-Sphere Water Clusters Tune the Lanthanide Selectivity of Diglycolamides.

Baldwin AG, Ivanov AS, Williams NJ, Ellis RJ, Moyer BA, Bryantsev VS, Shafer JC.

ACS Cent Sci. 2018 Jun 27;4(6):739-747. doi: 10.1021/acscentsci.8b00223. Epub 2018 Jun 14.

11.

Selective Solid-Liquid and Liquid-Liquid Extraction of Lithium Chloride Using Strapped Calix[4]pyrroles.

He Q, Williams NJ, Oh JH, Lynch VM, Kim SK, Moyer BA, Sessler JL.

Angew Chem Int Ed Engl. 2018 Sep 10;57(37):11924-11928. doi: 10.1002/anie.201805127. Epub 2018 Jun 19.

PMID:
29800493
12.

Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.

Moyer BD, Murray JK, Ligutti J, Andrews K, Favreau P, Jordan JB, Lee JH, Liu D, Long J, Sham K, Shi L, Stöcklin R, Wu B, Yin R, Yu V, Zou A, Biswas K, Miranda LP.

PLoS One. 2018 May 3;13(5):e0196791. doi: 10.1371/journal.pone.0196791. eCollection 2018.

13.

RPtag as an Orally Bioavailable, Hyperstable Epitope Tag and Generalizable Protein Binding Scaffold.

DeRosa JR, Moyer BS, Lumen E, Wolfe AJ, Sleeper MB, Bianchi AH, Crawford A, McGuigan C, Wortel D, Fisher C, Moody KJ, Blanden AR.

Biochemistry. 2018 May 29;57(21):3036-3049. doi: 10.1021/acs.biochem.8b00170. Epub 2018 May 15.

PMID:
29722979
14.

1,2,4-Triazolsulfone: A novel isosteric replacement of acylsulfonamides in the context of NaV1.7 inhibition.

Boezio AA, Andrews K, Boezio C, Chu-Moyer M, Copeland KW, DiMauro EF, Foti RS, Fremeau RT Jr, Gao H, Geuns-Meyer S, Graceffa RF, Gunaydin H, Huang H, La DS, Ligutti J, Moyer BD, Peterson EA, Yu V, Weiss MM.

Bioorg Med Chem Lett. 2018 Jun 15;28(11):2103-2108. doi: 10.1016/j.bmcl.2018.04.035. Epub 2018 Apr 17.

PMID:
29709252
15.

Trefoil-Shaped Outer-Sphere Ion Clusters Mediate Lanthanide(III) Ion Transport with Diglycolamide Ligands.

Brigham DM, Ivanov AS, Moyer BA, Delmau LH, Bryantsev VS, Ellis RJ.

J Am Chem Soc. 2017 Dec 6;139(48):17350-17358. doi: 10.1021/jacs.7b07318. Epub 2017 Nov 14.

PMID:
29083173
16.

Recovery of Lithium from Geothermal Brine with Lithium-Aluminum Layered Double Hydroxide Chloride Sorbents.

Paranthaman MP, Li L, Luo J, Hoke T, Ucar H, Moyer BA, Harrison S.

Environ Sci Technol. 2017 Nov 21;51(22):13481-13486. doi: 10.1021/acs.est.7b03464. Epub 2017 Nov 9.

PMID:
29076733
17.

Obesity and fatty liver are prevented by inhibition of the aryl hydrocarbon receptor in both female and male mice.

Moyer BJ, Rojas IY, Kerley-Hamilton JS, Nemani KV, Trask HW, Ringelberg CS, Gimi B, Demidenko E, Tomlinson CR.

Nutr Res. 2017 Aug;44:38-50. doi: 10.1016/j.nutres.2017.06.002. Epub 2017 Jun 28.

18.

Engineering Antibody Reactivity for Efficient Derivatization to Generate NaV1.7 Inhibitory GpTx-1 Peptide-Antibody Conjugates.

Biswas K, Nixey TE, Murray JK, Falsey JR, Yin L, Liu H, Gingras J, Hall BE, Herberich B, Holder JR, Li H, Ligutti J, Lin MJ, Liu D, Soriano BD, Soto M, Tran L, Tegley CM, Zou A, Gunasekaran K, Moyer BD, Doherty L, Miranda LP.

ACS Chem Biol. 2017 Sep 15;12(9):2427-2435. doi: 10.1021/acschembio.7b00542. Epub 2017 Aug 28.

PMID:
28800217
19.

Discovery of a biarylamide series of potent, state-dependent NaV1.7 inhibitors.

Schenkel LB, DiMauro EF, Nguyen HN, Chakka N, Du B, Foti RS, Guzman-Perez A, Jarosh M, La DS, Ligutti J, Milgram BC, Moyer BD, Peterson EA, Roberts J, Yu VL, Weiss MM.

Bioorg Med Chem Lett. 2017 Aug 15;27(16):3817-3824. doi: 10.1016/j.bmcl.2017.06.054. Epub 2017 Jun 26.

PMID:
28684121
20.

The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: Tools that bridge efficacy and target engagement.

La DS, Peterson EA, Bode C, Boezio AA, Bregman H, Chu-Moyer MY, Coats J, DiMauro EF, Dineen TA, Du B, Gao H, Graceffa R, Gunaydin H, Guzman-Perez A, Fremeau R Jr, Huang X, Ilch C, Kornecook TJ, Kreiman C, Ligutti J, Jasmine Lin MH, McDermott JS, Marx I, Matson DJ, McDonough SI, Moyer BD, Nho Nguyen H, Taborn K, Yu V, Weiss MM.

Bioorg Med Chem Lett. 2017 Aug 1;27(15):3477-3485. doi: 10.1016/j.bmcl.2017.05.070. Epub 2017 Jun 1.

PMID:
28629594
21.

Capping the calix: how toluene completes cesium(i) coordination with calix[4]pyrrole.

Ellis RJ, Reinhart B, Williams NJ, Moyer BA, Bryantsev VS.

Chem Commun (Camb). 2017 May 18;53(41):5610-5613. doi: 10.1039/c7cc02347b.

PMID:
28484775
22.

Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel NaV1.7.

Kornecook TJ, Yin R, Altmann S, Be X, Berry V, Ilch CP, Jarosh M, Johnson D, Lee JH, Lehto SG, Ligutti J, Liu D, Luther J, Matson D, Ortuno D, Roberts J, Taborn K, Wang J, Weiss MM, Yu V, Zhu DXD, Fremeau RT Jr, Moyer BD.

J Pharmacol Exp Ther. 2017 Jul;362(1):146-160. doi: 10.1124/jpet.116.239590. Epub 2017 May 4.

PMID:
28473457
23.

Bis-lactam-1,10-phenanthroline (BLPhen), a New Type of Preorganized Mixed N,O-Donor Ligand That Separates Am(III) over Eu(III) with Exceptionally High Efficiency.

Jansone-Popova S, Ivanov AS, Bryantsev VS, Sloop FV Jr, Custelcean R, Popovs I, Dekarske MM, Moyer BA.

Inorg Chem. 2017 May 15;56(10):5911-5917. doi: 10.1021/acs.inorgchem.7b00555. Epub 2017 May 4.

PMID:
28471188
24.

Correction to "Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement".

Marx IE, Dineen TA, Able J, Bode C, Bregman H, Chu-Moyer M, DiMauro EF, Du B, Foti RS, Fremeau RT Jr, Gao H, Gunaydin H, Hall BE, Huang L, Kornecook T, Kreiman CR, La DS, Ligutti J, Lin MJ, Liu D, McDermott JS, Moyer BD, Nguyen HN, Peterson EA, Roberts JT, Rose P, Wang J, Youngblood BD, Yu V, Weiss MM.

ACS Med Chem Lett. 2017 Feb 28;8(3):378. doi: 10.1021/acsmedchemlett.7b00075. eCollection 2017 Mar 9.

25.

Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.

Moyer BJ, Rojas IY, Murray IA, Lee S, Hazlett HF, Perdew GH, Tomlinson CR.

Toxicol Appl Pharmacol. 2017 May 15;323:74-80. doi: 10.1016/j.taap.2017.03.012. Epub 2017 Mar 20.

26.

Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity.

Graceffa RF, Boezio AA, Able J, Altmann S, Berry LM, Boezio C, Butler JR, Chu-Moyer M, Cooke M, DiMauro EF, Dineen TA, Feric Bojic E, Foti RS, Fremeau RT Jr, Guzman-Perez A, Gao H, Gunaydin H, Huang H, Huang L, Ilch C, Jarosh M, Kornecook T, Kreiman CR, La DS, Ligutti J, Milgram BC, Lin MJ, Marx IE, Nguyen HN, Peterson EA, Rescourio G, Roberts J, Schenkel L, Shimanovich R, Sparling BA, Stellwagen J, Taborn K, Vaida KR, Wang J, Yeoman J, Yu V, Zhu D, Moyer BD, Weiss MM.

J Med Chem. 2017 Jul 27;60(14):5990-6017. doi: 10.1021/acs.jmedchem.6b01850. Epub 2017 Apr 20.

PMID:
28324649
27.

Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities.

Weiss MM, Dineen TA, Marx IE, Altmann S, Boezio A, Bregman H, Chu-Moyer M, DiMauro EF, Feric Bojic E, Foti RS, Gao H, Graceffa R, Gunaydin H, Guzman-Perez A, Huang H, Huang L, Jarosh M, Kornecook T, Kreiman CR, Ligutti J, La DS, Lin MJ, Liu D, Moyer BD, Nguyen HN, Peterson EA, Rose PE, Taborn K, Youngblood BD, Yu V, Fremeau RT Jr.

J Med Chem. 2017 Jul 27;60(14):5969-5989. doi: 10.1021/acs.jmedchem.6b01851. Epub 2017 Apr 20.

PMID:
28287723
28.

"Straining" to Separate the Rare Earths: How the Lanthanide Contraction Impacts Chelation by Diglycolamide Ligands.

Ellis RJ, Brigham DM, Delmau L, Ivanov AS, Williams NJ, Vo MN, Reinhart B, Moyer BA, Bryantsev VS.

Inorg Chem. 2017 Feb 6;56(3):1152-1160. doi: 10.1021/acs.inorgchem.6b02156. Epub 2016 Nov 23.

PMID:
28161941
29.

Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement.

Marx IE, Dineen TA, Able J, Bode C, Bregman H, Chu-Moyer M, DiMauro EF, Du B, Foti RS, Fremeau RT Jr, Gao H, Gunaydin H, Hall BE, Huang L, Kornecook T, Kreiman CR, La DS, Ligutti J, Lin MJ, Liu D, McDermott JS, Moyer BD, Peterson EA, Roberts JT, Rose P, Wang J, Youngblood BD, Yu V, Weiss MM.

ACS Med Chem Lett. 2016 Sep 21;7(12):1062-1067. eCollection 2016 Dec 8. Erratum in: ACS Med Chem Lett. 2017 Feb 28;8(3):378.

30.

Evaluation of recombinant monoclonal antibody SVmab1 binding to Na V1.7 target sequences and block of human Na V1.7 currents.

Liu D, Tseng M, Epstein LF, Green L, Chan B, Soriano B, Lim D, Pan O, Murawsky CM, King CT, Moyer BD.

F1000Res. 2016 Nov 25;5:2764. eCollection 2016.

31.

Selective antagonism of TRPA1 produces limited efficacy in models of inflammatory- and neuropathic-induced mechanical hypersensitivity in rats.

Lehto SG, Weyer AD, Youngblood BD, Zhang M, Yin R, Wang W, Teffera Y, Cooke M, Stucky CL, Schenkel L, Geuns-Meyer S, Moyer BD, Wild KD, Gavva NR.

Mol Pain. 2016 Nov 29;12. pii: 1744806916677761. Print 2016.

32.

Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent NaV1.7 inhibitors.

Sparling BA, Yi S, Able J, Bregman H, DiMauro EF, Foti RS, Gao H, Guzman-Perez A, Huang H, Jarosh M, Kornecook T, Ligutti J, Milgram BC, Moyer BD, Youngblood B, Yu VL, Weiss MM.

Medchemcomm. 2016 Dec 2;8(4):744-754. doi: 10.1039/c6md00578k. eCollection 2017 Apr 1.

33.

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES BIODOSIMETRY AND RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE PROGRAMS.

Homer MJ, Raulli R, DiCarlo-Cohen AL, Esker J, Hrdina C, Maidment BW, Moyer B, Rios C, Macchiarini F, Prasanna PG, Wathen L.

Radiat Prot Dosimetry. 2016 Sep;171(1):85-98. doi: 10.1093/rpd/ncw226. Epub 2016 Sep 2.

34.

Group Hexavalent Actinide Separations: A New Approach to Used Nuclear Fuel Recycling.

Burns JD, Moyer BA.

Inorg Chem. 2016 Sep 6;55(17):8913-9. doi: 10.1021/acs.inorgchem.6b01430. Epub 2016 Aug 17.

PMID:
27532485
35.

Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.

DiMauro EF, Altmann S, Berry LM, Bregman H, Chakka N, Chu-Moyer M, Bojic EF, Foti RS, Fremeau R, Gao H, Gunaydin H, Guzman-Perez A, Hall BE, Huang H, Jarosh M, Kornecook T, Lee J, Ligutti J, Liu D, Moyer BD, Ortuno D, Rose PE, Schenkel LB, Taborn K, Wang J, Wang Y, Yu V, Weiss MM.

J Med Chem. 2016 Sep 8;59(17):7818-39. doi: 10.1021/acs.jmedchem.6b00425. Epub 2016 Aug 29.

PMID:
27441383
36.

Tandem dissolution of UO3 in amide-based acidic ionic liquid and in situ electrodeposition of UO2 with regeneration of the ionic liquid: a closed cycle.

Wanigasekara E, Freiderich JW, Sun XG, Meisner RA, Luo H, Delmau LH, Dai S, Moyer BA.

Dalton Trans. 2016 Jun 21;45(25):10151-4. doi: 10.1039/c6dt00873a.

PMID:
27255672
37.

Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.

Moyer BJ, Rojas IY, Kerley-Hamilton JS, Hazlett HF, Nemani KV, Trask HW, West RJ, Lupien LE, Collins AJ, Ringelberg CS, Gimi B, Kinlaw WB 3rd, Tomlinson CR.

Toxicol Appl Pharmacol. 2016 Jun 1;300:13-24. doi: 10.1016/j.taap.2016.03.011. Epub 2016 Mar 25.

38.

Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1.

Murray JK, Long J, Zou A, Ligutti J, Andrews KL, Poppe L, Biswas K, Moyer BD, McDonough SI, Miranda LP.

J Med Chem. 2016 Mar 24;59(6):2704-17. doi: 10.1021/acs.jmedchem.5b01947. Epub 2016 Mar 10.

PMID:
26890998
39.

Computer-Aided Molecular Design of Bis-phosphine Oxide Lanthanide Extractants.

McCann BW, Silva ND, Windus TL, Gordon MS, Moyer BA, Bryantsev VS, Hay BP.

Inorg Chem. 2016 Jun 20;55(12):5787-803. doi: 10.1021/acs.inorgchem.5b02995. Epub 2016 Feb 17.

PMID:
26883005
40.

Silver(I)-Catalyzed Diastereoselective Synthesis of anti-1,2-Hydroxyboronates.

Joannou MV, Moyer BS, Goldfogel MJ, Meek SJ.

Angew Chem Int Ed Engl. 2015 Nov 16;54(47):14141-5. doi: 10.1002/anie.201507171. Epub 2015 Sep 25.

PMID:
26404842
41.

Critical Materials Recovery from Solutions and Wastes: Retrospective and Outlook.

Diallo MS, Baier G, Moyer BA, Hamelers B.

Environ Sci Technol. 2015 Aug 18;49(16):9387-9. doi: 10.1021/acs.est.5b03694. No abstract available.

PMID:
26281889
42.

Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1.

Murray JK, Biswas K, Holder JR, Zou A, Ligutti J, Liu D, Poppe L, Andrews KL, Lin FF, Meng SY, Moyer BD, McDonough SI, Miranda LP.

Bioorg Med Chem Lett. 2015 Nov 1;25(21):4866-4871. doi: 10.1016/j.bmcl.2015.06.033. Epub 2015 Jun 16.

PMID:
26112439
43.

Development of a replication-competent lentivirus assay for dendritic cell-targeting lentiviral vectors.

Farley DC, McCloskey L, Thorne BA, Tareen SU, Nicolai CJ, Campbell DJ, Bannister R, Stewart HJ, Pearson LJ, Moyer BJ, Robbins SH, Zielinski L, Kim T, Radcliffe PA, Mitrophanous KA, Gombotz WR, Miskin JE, Kelley-Clarke B.

Mol Ther Methods Clin Dev. 2015 May 13;2:15017. doi: 10.1038/mtm.2015.17. eCollection 2015.

44.

Enantio- and Diastereoselective Synthesis of 1,2-Hydroxyboronates through Cu-Catalyzed Additions of Alkylboronates to Aldehydes.

Joannou MV, Moyer BS, Meek SJ.

J Am Chem Soc. 2015 May 20;137(19):6176-9. doi: 10.1021/jacs.5b03477. Epub 2015 May 12.

PMID:
25905917
45.

Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.

Murray JK, Ligutti J, Liu D, Zou A, Poppe L, Li H, Andrews KL, Moyer BD, McDonough SI, Favreau P, Stöcklin R, Miranda LP.

J Med Chem. 2015 Mar 12;58(5):2299-314. doi: 10.1021/jm501765v. Epub 2015 Feb 19.

PMID:
25658507
46.

Voltage-gated sodium channel function and expression in injured and uninjured rat dorsal root ganglia neurons.

Yin R, Liu D, Chhoa M, Li CM, Luo Y, Zhang M, Lehto SG, Immke DC, Moyer BD.

Int J Neurosci. 2016;126(2):182-92. doi: 10.3109/00207454.2015.1004172. Epub 2015 Apr 7.

PMID:
25562420
47.

Recovery of uranium from wet phosphoric acid by solvent extraction processes.

Beltrami D, Cote G, Mokhtari H, Courtaud B, Moyer BA, Chagnes A.

Chem Rev. 2014 Dec 24;114(24):12002-23. doi: 10.1021/cr5001546. Epub 2014 Nov 17. No abstract available.

PMID:
25400258
48.

Crown ethers in graphene.

Guo J, Lee J, Contescu CI, Gallego NC, Pantelides ST, Pennycook SJ, Moyer BA, Chisholm MF.

Nat Commun. 2014 Nov 13;5:5389. doi: 10.1038/ncomms6389.

PMID:
25391367
49.

The use of electronic games in therapy: a review with clinical implications.

Horne-Moyer HL, Moyer BH, Messer DC, Messer ES.

Curr Psychiatry Rep. 2014 Dec;16(12):520. doi: 10.1007/s11920-014-0520-6. Review.

50.

Bipyrrole-strapped calix[4]pyrroles: strong anion receptors that extract the sulfate anion.

Kim SK, Lee J, Williams NJ, Lynch VM, Hay BP, Moyer BA, Sessler JL.

J Am Chem Soc. 2014 Oct 22;136(42):15079-85. doi: 10.1021/ja5086996. Epub 2014 Oct 8.

PMID:
25254498

Supplemental Content

Support Center